Paul Ivor Dargan - Toxicology

Author Information

Paul Ivor Dargan is affiliated with the Clinical Toxicology department at Guy's and St Thomas' NHS Foundation Trust in London, UK. He is a prominent figure in the field of toxicology with a particular focus on substance use disorders and the impacts of various toxins on human health.

Research Contributions

Paul Ivor Dargan has made significant contributions to the field of toxicology through his extensive research on various substances and their effects on human health. His work in 2022 covers a wide range of topics, including the mental health burden among young people in Europe, the detection of novel psychoactive substances, the clinical impact of cannabis and ethanol co-use, and the online availability of controlled substances. His research not only provides critical insights into the clinical features of substance intoxication but also examines the broader public health implications such as lead poisoning and the non-medical use of over-the-counter codeine.

Aliases

Paul Ivor Dargan is known by several aliases, including P.i. Dargan, P Dargan, P I Dargan, Paul I. Dargan, Paul I Dargan, P. I. Dargan, P. Dargan, and Paul Dargan. These variations are likely due to different conventions in academic publishing.

Publication and Citation Metrics

Metric	Value
Total Citation Count	41,396
H-Index	71
Total Paper Count	413

Publications:

The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019

DOI: 10.1016/j.lanepe.2022.100341

Year: 2022

Isotonitazene, a novel psychoactive substance opioid, detected in two cases following a local surge in opioid overdoses.

DOI: 10.1093/qjmed/hcac039

Year: 2022

Bicytopenia and neurological defects caused by zinc toxicity.

DOI: 10.1111/bjh.18171

Year: 2022

Differences in clinical features associated with cannabis intoxication in presentations to European emergency departments according to patient age and sex.

DOI: 10.1080/15563650.2022.2060116

Year: 2022

Lead poisoning among asymptomatic individuals with a long-term history of opiate use in Golestan Cohort Study.

DOI: 10.1016/j.drugpo.2022.103695

Year: 2022

Clinical effect of ethanol co-use in patients with acute drug toxicity involving the use of central nervous system depressant recreational drugs.

DOI: 10.1097/MEJ.0000000000000932

Year: 2022

The association between the availability of over the counter codeine and the prevalence of non-medical use.

DOI: 10.1007/s00228-021-03158-1

Year: 2022

Excretion of mephedrone and its phase I metabolites in urine after a controlled intranasal administration to healthy human volunteers.

DOI: 10.1002/dta.3214

Year: 2022

Machine learning to assist in large-scale, activity-based synthetic cannabinoid receptor agonist screening of serum samples.

DOI: 10.1093/clinchem/hvac027

Year: 2022

Online availability of gabapentin and pregabalin and the impact of legal reclassification in the United Kingdom

DOI: 10.1080/09687637.2020.1799943

Year: 2022

What Factors Influence NPV in Toxicology?

What are Cardiotoxic Agents?

What are Wearable Sensors?

Is Echinacea Purpurea Safe?

What are the Routes of Exposure to Plutonium?

What Are the Symptoms of Bone Marrow Suppression?

What Are Common Sources of Occupational Exposure?

What Are Common Toxins That Affect the Stomach?

What Are Natural Flavors?

What is Bioactivation?

Partnered Content Networks

Relevant Topics